Meningococcal vaccine groups A C Y W-135 polysaccharide (Beijing Minhai Biotechnology)

ACYW135群脑膜炎球菌多糖疫苗（北京民海生物科技）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeningococcal vaccine groups A C Y W-135 polysaccharide (Beijing Minhai Biotechnology)
Drug Alias Name4-valent Meningococcal Polysaccharide Vaccine
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisMeningitis, Meningococcal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesBeijing Minhai Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Minhai Biotechnology Co Ltd
Inactive CompaniesShenzhen Kangtai Biological Products Co Ltd
Active IndicationsMeningitis, Meningococcal
Inactive IndicationsMeningitis

Other Information

ATC CodeN/A
Related LinksN/A